Osteoporosis identification and management in primary care
- MeSH Terms
- Osteoporosis [C05.116.198.579] ; Osteoporosis, Postmenopausal [C05.116.198.579.610]; Osteoporotic Fractures [C26.404.545]; Bone Density Conservation Agents [D27.505.696.242]Alendronate [D02.705.429.500.100]; Ibandronic Acid [D02.705.429.500.844]; Risedronic Acid [D02.705.429.500.872]; Zoledronic Acid [D02.705.429.500.942]; Denosumab [D12.776.124.486.485.114.224.060.782]; Teriparatide [D06.472.699.590.850]
- Guideline Contact
- Agency for Care Effectiveness
- English Title Translation
- NA
- Keywords
- bone density, osteoporosis, fracture, OSTA, FRAX
- Date for Review
- 07-Nov-23
- Publication Date
- 07-Nov-18
- Expected Publication Date
- 17-Feb-25
- Methods Applied
- GRADE; AGREE II; RAND/UCLA; Systematic search of guidelines; systematic searches; risk of bias
- Publication Scope
- assessment
- Prevention
- Management
- Treatment
- Countries of Application
- Singapore
- Guideline Publication Status
- Review
- Languages
- English
- Authors
- Agency for Care Effectiveness Singapore
- Willingness to Collaborate
- Yes
- Publication Year
- 2018
- Name of Endorsing Organization
- Ministry of Health Singapore